Patents
Patents for C07C 225 - Compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly-bound oxygen atoms not being part of a cho group, e.g. amino ketones (4,302)
03/2004
03/10/2004CN1480450A 2-aminopropane-1,3-glycol compound, its use as medicine and its synthetic intermediate
03/04/2004US20040044061 Analgesics; side effect reduction
03/04/2004US20040044059 Tubulin binding ligands and corresponding prodrug constructs
03/04/2004US20040043969 Tubulin binding agents and corresponding prodrug constructs
03/03/2004EP1392269A1 Novel arylaminopropane analogues and their use for the treatment of glaucoma
03/02/2004US6699898 Method of treating coronary artery disease or other cetp-mediated disorders in a subject by administering a therapeutically effective amount of a compound of one of claims
03/02/2004US6699893 Glucocorticoid receptor modulators
02/2004
02/26/2004WO2003097575A3 Amino-functional chalcones
02/26/2004WO2003097574A3 Aminoalkoxy-functional chalcones
02/26/2004WO2002057211A8 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use
02/26/2004US20040039234 Process for synthesis of alpha,beta-unsaturated ketones
02/26/2004US20040039043 Amidobiphenyloxime derivatives, useful as fungicide or bactericide for protection of crops and materials
02/26/2004US20040035293 Melt point is < 100 degrees c; provides distinct selectivities and reactivities because they are made of ions rather than molecules
02/25/2004EP1390337A1 Precursors for ketones and aldehydes
02/25/2004EP0873301B1 Indane compounds with smooth muscle relaxing and/or mast cell stabilising and/or anti-inflammatory activity
02/25/2004CN1478074A Cyclohexyl (alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
02/24/2004US6696571 Process for producing α-aminoketones
02/24/2004US6696472 Substituted N-phenoxy-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
02/24/2004US6696435 For treating atherosclerosis, other coronary artery diseases; 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for example
02/19/2004WO2004014550A2 Novel nickel-carbene, palladium-carbene and platinum-carbene complexes, their production and use in catalytic reactions
02/19/2004US20040034246 Radiofluorinated imaging agents which are utilzed in Positron Emission Tomography for diagonsis of Parkinson's disease
02/18/2004CN1476424A 萘衍生物 Naphthalene Derivatives
02/18/2004CN1138777C Photoactivatable nitrogen-containing bases based on alpha-amino ketones
02/17/2004CA2051501C 1-phenyl-3-phenyl-2-propyne-1-ones as calcium uptake inhibitors
02/12/2004WO2004013077A2 Cyclopentanone and cyclopentanone derivatives as potent activators of hsf-1
02/12/2004DE10057415B4 Verfahren zur Herstellung von Chinon-Derivaten und deren Verwendung Process for the preparation of quinone derivatives and the use thereof
02/12/2004CA2495030A1 Cyclopentanone and cyclopentanone derivatives as potent activators of hsf-1
02/11/2004EP1123271A4 Novel amine and quaternary ammonium compounds made from ketones and aldehydes, and compositions containing them
02/11/2004EP1099687B1 Process for producing 2-aminobenzophenone compound
02/10/2004US6689427 Group IV metal precursors and a method of chemical vapor deposition using the same
02/05/2004WO2004011418A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands
02/05/2004WO2004011410A1 Chemical compounds
02/05/2004CA2494668A1 Chemical compounds
02/04/2004CN1473034A Photo-labile pro-fragrance conjugates
02/04/2004CN1137086C 2-aminopropane-1,3-diol compounds, medical use therof and intermediates in synthesizing the same
02/04/2004CN1137084C Aryne intermediates and process for preparation thereof
01/2004
01/29/2004US20040019106 Cyano and carboxy derivatives of substituted styrenes; inhibitors of tumor necrosis factor alpha, nuclear factor kappa B, and phosphodiesterase
01/28/2004CN1471506A Method for preparing carbonyl alpha-substituted nitrogen compounds
01/27/2004US6683214 Reacting a n-protected aminoacid ester with halomethyllithium compound; then acid
01/27/2004US6683099 Substituted N,N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
01/27/2004US6683087 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use
01/22/2004WO2004007426A1 Fullerene compounds
01/21/2004EP1381590A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
01/15/2004WO2004005239A1 PROCESS FOR THE PREPARATION OF N-MONOSUBSTITUTED β-AMINO ALCOHOLS
01/15/2004US20040010149 Ligand for transition metal complex catalyst
01/14/2004EP1379239A2 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor
01/14/2004EP1379234A1 Halogenated aminobenzophenones and aminobenzoylpyridines as inhibitors of il-1 and tnf
01/14/2004EP1212292B1 (-)-verbenone derivatives
01/14/2004CN1134457C New alpha-aminoacetophenone photoinitiators
01/13/2004US6677382 Halogenated oxyamines, used as enzyme inhibitors for prophylaxis of atherosclerosis and cardiovascular disorders, and as antilipemic agents
01/13/2004US6677380 Antilipemic agents such as 3(3-(4-chloro-3-ethyl-phenoxy)-phenyl)((3-(1,1,2,2 -tetrafluoroethoxy)phenyl)methyl))amino)-1,1,1-trifluro-2-propanthiol, used for prophlaxis of cardiovascular disorders and atherosclerosis
01/13/2004US6677379 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease
01/13/2004US6677375 Substituted N,N-bis-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
01/13/2004US6677353 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
01/08/2004WO2004002947A1 Phenoxypropenylphenyl derivatives and their use as herbicides
01/08/2004WO2003087035A8 2,5-bis-diamine-'1,4! benzoquinone derivatives for the treatment of alzheimer's disease a process for their preparation and intermediates therefor
01/08/2004US20040005637 Intermediate products coupled to solid polymeric support suitable for synthesis of heterocyclic compounds in simple and fast methods on solid phase; for synthesis of heterocycles with large structural diversity in high yields
01/07/2004EP1378505A1 Method of synthesizing camptothecin-relating compounds
01/07/2004EP1377593A2 2-amino-propanol derivatives
01/07/2004EP1377290A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
01/02/2004EP1372632A1 Proliferative activator receptor (ppar) compounds
12/2003
12/30/2003US6670332 Cytofectins comprising complex amphiphilic lipids in which a bioactive agent which is recognized by biological systems is joined to a Rosenthal Inhibitor core structure through an alkyl linking group
12/24/2003WO2003106399A2 PROCESS FOR PREPARING N-PROTECTED beta-AMINO ALDEHYDE COMPOUNDS
12/24/2003WO2003040174A3 Substituted amino ketone compounds
12/18/2003WO2003104186A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE ß-AMINO ALCOHOL
12/18/2003US20030233010 Reacting with ozone, or sodium periodate, cleaving a carbon-carbon double bond, acetalization; forming a synthetic intermediates for preparing glycopeptide antibiotics
12/18/2003US20030232786 For prevention and/or treatment of cancer, Alzheimer's disease, Parkinson's disease, multiple sclerosis, amyotropic lateral sclerosis, rheumatoid arthritis, inflammatory bowel disease
12/17/2003CN1131204C Process for preparing 2-aminobenzophenone compound
12/16/2003US6664272 Such as 1,5-Bis-(2, 4-difluorophenyl)penta-1,4-diene-3 -one; administering to inhibit tissue factor and vascular endothelial growth factor (VEGF) production in cancerous tissue
12/11/2003WO2003101933A1 Intermediate products, methods for their preparation and use thereof
12/11/2003US20030229148 2-aminotetralines, a process for their preparation, and pharmaceutical compositions, for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies
12/11/2003CA2487659A1 Intermediate products, methods for their preparation and use thereof
12/10/2003EP1368287A1 Process for a homogeneously catalyzed c-c coupling reaction
12/04/2003WO2003099769A1 Anilino liver x-receptor modulators
12/04/2003US20030225294 Condensing 1,4-dihydroxyanthraquinone with p-toluidine in the presence of boric acid and aprotic solvents, to form anthraquinone dyes used for coloring plastics
12/04/2003US20030225179 Carbocyclic oxo, amines used as photoinitiators, formed by reacting 1-(4-(bis-(2-hydroxyethyl)-amino))-2-methyl-2-morpholino-1-propanone with caprolactone in the presence of catalysts; inks
12/04/2003CA2486644A1 Anilino liver x-receptor modulators
12/03/2003EP1367046A1 Disubstituted lavendustin A analogs and pharmaceutical compositions comprising the analogs
12/03/2003EP1367045A1 Intermediate products, methods for their preparation and use thereof
12/03/2003EP1366064A1 Tumour targeting prodrugs activated by metallo matrixproteinases
12/03/2003CN1459445A Process for preparing N,N-twice substituted 1,4-diamino anthraquinone
12/02/2003US6657084 Arylamine compound and organic electroluminescence device
11/2003
11/27/2003WO2003097577A1 Chemical compound consisting of a nitrogenous chalcone derivative, method of producing one such chemical compound and filtering and/or cosmetic composition containing same
11/27/2003WO2003097576A2 Diamino-functional chalcones
11/27/2003WO2003097575A2 Amino-functional chalcones
11/27/2003WO2003097574A2 Aminoalkoxy-functional chalcones
11/27/2003WO2003097568A1 Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative
11/26/2003EP1364993A1 Process for the preparation of N,N'-disubstituted diaminoanthraquinones
11/26/2003CN1458921A Process for making N-aryl-anthranilic acid and their derivatives
11/25/2003US6653508 Use treating various medical conditions, including pain
11/21/2003CA2428957A1 Process for the preparation of n,n'-disubstituted 1,4-diaminoanthraquinones
11/19/2003EP1017667B1 2-Amino-6-methyl-7-acetyl-tetraline and pharmaceutical compositions for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies
11/18/2003US6649783 Synthesis of (+/-)-2-((dimethylamino)methyl)-1-(aryl)cyclohexanols
11/18/2003US6649658 (−)-Verbenone derivatives
11/13/2003WO2001040188A8 Curcumin analogues for treating cancer
11/13/2003US20030212143 Analgesics, anesthetics; crystallization, resolution
11/12/2003EP1361210A2 Novel immunotherapeutic agents and their use in the reduction of cytokine levels
11/12/2003EP1360167A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use
11/12/2003EP1359889A2 Primary intermediate for oxidative coloration of hair
11/12/2003CN1127470C Novel tetralone or benzopyranone derivatives and process for producing same
1 ... 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ... 44